한국어
English
日本語
中文(简体)
Harvoni
90mg
Tablet · Prescription medication · Combination
Gilead Sciences Korea, Co., Ltd.
Redipasvir is an antiviral ingredient used for the treatment of Hepatitis C virus.
MFDS ingredient code M262910
Redipasvir belongs to a class of antivirals that inhibit the replication of the Hepatitis C virus. It is primarily used to suppress viral proliferation in chronic Hepatitis C patients to prevent liver damage.
Redipasvir blocks the proteins necessary for the virus to replicate its genetic material, thereby preventing viral proliferation. This reduces the viral load in the body and helps prevent deterioration of liver function.
Approved uses differ by product. Check each product's information for its actual use.
Redipasvir is a specialized NS5A protein inhibitor for Hepatitis C treatment, used in combination with other antivirals to reduce the development of resistance and enhance treatment efficacy. Unlike other antivirals, this ingredient has the characteristic of directly inhibiting the function of the viral replication complex.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.